The White House released a healthcare framework as a call to action. It offers few specifics and raises more questions than answers on each point of the 1½-page plan.
Congressional appropriations package expands reporting obligations for PBMs to increase transparency. It also delinks PBM compensation in Medicare from list prices.
Rising costs coupled by flat rates set by the Trump administration for Medicare Advantage could trigger withdrawals of health insurers from markets across the U.S.
A recent study projects a marked rise in sleep apnea by 2050. Perhaps this projection may be in for a change.
A ceiling “maximum fair price” established by the Inflation Reduction Act will end up being an important driver of substantially lower prices for this round of 15 drugs.
Dr. Omer Awan, physician and public health expert, breaks down the latest data as well as health disparities associated with cancers globally.
Socks are more important than you may think during the Arctic plunge currently gripping much of the U.S. Here’s why feet are so important in regulating body temperature.
The Trump administration says that while it is pushing for lower prices in the U.S. drugmakers will be able to make up the difference by charging higher prices abroad.
Longevity medicine is becoming more mainstream. While benefits exists, an expert physician wants patients to remain cautious of information they read or view online.
The Nipah virus may cause significant neurological disease and respiratory failure.